Clinical trials
Phase 1 Myeloproliferative Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2016 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Terminated | 4 |
| Completed | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 4 |
| National Cancer Institute (NCI) | 2 |
| Astex Pharmaceuticals, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Pfizer | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myeloproliferative Disorders | 10 |
| Primary Myelofibrosis | 7 |
| Leukemia, Myeloid, Acute | 5 |
| Leukemia, Myelomonocytic, Chronic | 4 |
| Myelodysplastic Syndromes | 4 |
| Thrombocythemia, Essential | 4 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3 |
| Recurrence | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Leukemia, Promyelocytic, Acute | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.